[{"id":"2674053c-0b8b-4f15-84e1-05d33278bb8a","acronym":"","url":"https://clinicaltrials.gov/study/NCT06041516","created_at":"2023-09-18T15:13:22.199Z","updated_at":"2024-07-02T16:34:25.938Z","phase":"Phase 1","brief_title":"Antibody Drug Conjugate ADCT-701 in Neuroendocrine Tumors and Carcinomas","source_id_and_acronym":"NCT06041516","lead_sponsor":"National Cancer Institute (NCI)","biomarkers":" CD4","pipe":"","alterations":" ","tags":["CD4"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e ADCT-701"],"overall_status":"Recruiting","enrollment":" Enrollment 70","initiation":"Initiation: 06/19/2024","start_date":" 06/19/2024","primary_txt":" Primary completion: 10/30/2027","primary_completion_date":" 10/30/2027","study_txt":" Completion: 10/30/2029","study_completion_date":" 10/30/2029","last_update_posted":"2024-06-14"}]